0RQD.LSE Essity AB Series B

Consumer Defensive Commercial Services & Supplies London Exchange
- SEK
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
2.89%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2023.

Is 0RQD.LSE undervalued?

Graham number

The Graham number of Essity AB Series B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Essity AB Series B fundamental analysis

No fundamental analysis for Essity AB Series B yet.

Essity AB Series B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Essity AB Series B

Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, …

Full company profile